(Q53388830)

13 May 2018

title

Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. (English)

1 reference

13 May 2018

cervical squamous cell carcinoma

1 reference

1 reference

based on heuristic

inferred from title

human papillomavirus infection

1 reference

Takaaki Sano

1

1 reference

13 May 2018

Norihiro Masuda

series ordinal

2

1 reference

13 May 2018

Tetsunari Oyama

series ordinal

3

1 reference

13 May 2018

Takashi Nakajima

series ordinal

4

1 reference

13 May 2018

publication date

1 May 2002

1 reference

13 May 2018

published in

Pathology International

1 reference

13 May 2018

volume

52

1 reference

13 May 2018

issue

5-6

1 reference

13 May 2018

page(s)

375-383

1 reference

13 May 2018

Papillomavirus infections--a major cause of human cancers

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

p14ARF links the tumour suppressors RB and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

The INK4A/ARF locus and its two gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

Nucleolar Arf sequesters Mdm2 and activates p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1827.2002.01359.X

10.1046/J.1440-1827.2002.01359.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018